Caplin Point is consolidating for growth, eyeing expansion in Latin America and the US with strong future potential.

Central drug regulator may retain GMP relaxations under Schedule M for disinfectants, medical gases and capsules after DTAB recommendation ...

Biologic advantage won’t come from better biology alone, but from delivery technology and designing the full experience ...

A new market analysis projects a compound annual growth rate of 9.8%, driven by the expanding biologics pipeline and a ...

Advancing U.S.-based cGMP manufacturing to support clinical and future commercial objectives of a novel siRNA therapy ...

If you are interested in meeting with Lifecore during this event, please reach out to us at: cdmo@lifecore.com.

Asia Pacific leads market growth, driven by rapid pharmaceutical manufacturing expansion and healthcare infrastructure ...

K.C. Pharmaceuticals has issued a massive voluntary recall involving more than 3.1 million bottles of over-the-counter eye drops. The move comes after ...

Representatives of Intercon Chemical Company (Intercon) have announced the introduction of a new portfolio of Branded Products - Cleaner MD and Cleaner LS, expanding the company's brand offerings into ...

Drug developers weigh building internal radiopharmaceutical capabilities versus outsourcing amid timeline and funding ...

As the rapid expansion of biologics continues, today’s high‑concentration injectables, prefilled syringes and cartridges, as ...

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted ...